Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study

Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study

Abstract Background and Objective Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treated with LEN. Methods In this multicenter retrospect...

Full description

Bibliographic Details
Main Authors: Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-02-01
Series:Drugs - Real World Outcomes
Online Access:https://doi.org/10.1007/s40801-020-00179-7

Internet

https://doi.org/10.1007/s40801-020-00179-7

Similar Items